Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal

Pneumococcal infections are the leading cause of vaccine-preventable death in children. In June 2015, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the Portuguese Immunization Program. We evaluated the cost-effectiveness of children vaccinated with PCV13 versus no vaccinatio...

Full description

Bibliographic Details
Main Author: Gouveia, M (author)
Other Authors: Fiorentino, F (author), Jesus, G (author), Costa, J (author), Borges, M (author)
Format: article
Language:eng
Published: 2019
Subjects:
Child, Preschool
Cost-Benefit Analysis
Humans
Incidence
Infant
Immunization
Models, Immunological
Pneumococcal Infections
Pneumococcal Vaccines
CHLC FAR
Online Access:http://hdl.handle.net/10400.17/3234
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/3234

Internet

http://hdl.handle.net/10400.17/3234

Similar Items